Anika Therapeutics, Inc. is a joint preservation company that creates and delivers advancements in early intervention orthopedic care. Its primary operational focus centers on osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone-preserving joint technologies. The enterprise develops, manufactures, and commercializes a broad suite of therapeutic products and medical devices utilizing its proprietary hyaluronic acid technology platform to treat joint diseases and support tissue healing globally.